Search Results for "Mpgn Kidney Disease In Adults With Cll"
Original Source: Pilot Study of Rituximab for Membranoproliferative Glomerulonephritis
Membranoproliferative glonerulonephritis (MPGN) is a relatively-rare, immune-mediated kidney disease. All current therapies are inadequate and MPGN frequently leads to kidney failure. This study is a 10 patient trial of the monoclonal antibody rituximab for adult patients with MPGN. Study patients will receive 2 doses of rituximab intravenously on days 1 and 15 and will then be followed for 1 year.
Matching Channels
Matching News
Pathogenesis of the C3 glomerulopathies and reclassification of MPGN
Improved understanding of the role of complement in the pathogenesis of a number of glomerular diseases has led to progress in disease classification and treatment. In this Review, Bomback and Appel r...
March Is National Kidney Month. What You Need To Know To Keep Your Kidney's Healthy
With more than 20 million or one in 10 American adults having some level of chronic kidney disease, the need for proper kidney health education is crucial.�According to Dr. Kozin, "Early kidney di...
March Is National Kidney Month. What You Need To Know To Keep Your Kidneys Healthy
With more than 20 million or one in 10 American adults having some level of chronic kidney disease, the need for proper kidney health education is crucial. According to Dr. Kozin, "Early kidney diseas...
Not Enough Data to Support Kidney Disease Screening, Task Force Says
MONDAY, Aug. 27 (HealthDay News) -- Too little evidence exists to determine the potential benefit and harms of screening all adults for chronic kidney disease, according to the U.S. Preventive Service...
Uninsured Americans More Likely to Progress to Kidney Disease, Death
ORLANDO, Fla.—Uninsured adults at high risk of kidney disease in the United States were more likely to progress to kidney failure or death than those with private health insurance coverage, accordin...
Antiplatelet agents for adults with chronic kidney disease?
Cochrane Database Syst Rev2013;2:CD008834Antiplatelet agents do not prevent deaths from cardiovascular disease or any other cause in adults with chronic kidney disease. In the first comprehensive......
Nearly 13% Canadian Adults Have Kidney Disease, Few Know It
OTTAWA, Ontario—Approximately 12.5 percent of Canadian adults—or 3 million people—have kidney disease, but few know it, according to a study published online May 6 in the Canadian Medical Associ...
Chronic Kidney Disease Increases Risk of Death for Women & Men
A new study from the Johns Hopkins Bloomberg School of Public Health and the Chronic Kidney Disease Prognosis Consortium (CKD-PC) found that in general chronic kidney disease is similarly associated w...
Matching PubMed Articles
C3 glomerulopathy: what's in a name?
Whereas early classifications of membranoproliferative glomerulonephritis (MPGN) were based on morphologic features, the modern approach is directed at immunofluorescence findings. Glomerular deposits...
Trends in pediatric primary membranoproliferative glomerulonephritis costs and complications.
BACKGROUND: Data on pediatric membranoproliferative glomerulonephritis (MPGN) epidemiology, complications, and healthcare costs are critical to our understanding of MPGN's economic burden and of how b...
The differential diagnosis of acute poststreptococcal glomerulonephritis (APSGN) and idiopathic membranoproliferative glomerulonephritis (MPGN) is sometimes difficult, as they share several key featur...
Membranoproliferative glomerulonephritis and circulating cryoglobulins.
BACKGROUND: Previous studies on membranoproliferative glomerulonephritis (MPGN) and cryoglobulinemic glomerulopathy (CG) were based upon case series that were performed before hepatitis C virus (HCV)...
Inverse association between body mass index and chronic kidney disease in older diabetic adults.
To identify associations among body mass index (BMI), diabetes, and chronic kidney disease (CKD) in older adults in Taiwan.
